Oriotx
Monthey, CH · 1 known investors
Orio Therapeutics develops protein-based therapeutics using a technology that modifies therapeutic proteins with a built-in delivery system to control their localization at the injection site, improving efficacy and reducing dosage in regenerative medicine. Its first application is a molecule to protect cardiac muscle following a heart attack (myocardial infarction) by reducing fibrosis and cellular death.
BiotechHealthtechMedical Devices
Founders & leadership
ZJ
Ziad JulierCo-founder & CEO
MM
Mikaël MartinoinCo-founder & CSO
Investors · 1
Frequently asked questions
- What does Oriotx do?
- Orio Therapeutics develops protein-based therapeutics using a technology that modifies therapeutic proteins with a built-in delivery system to control their localization at the injection site, improving efficacy and reducing dosage in regenerative medicine. Its first application is a molecule to protect cardiac muscle following a heart attack (myocardial infarction) by reducing fibrosis and cellular death.
- Who founded Oriotx?
- Oriotx was founded by Ziad Julier, Mikaël Martino.
- Who are Oriotx's investors?
- Oriotx's investors include Kickfund.
- Where is Oriotx headquartered?
- Oriotx is headquartered in Monthey, CH.